Summary
UnitedHealth Group (UNH) reported strong performance in its 2020 10-K filing, reflecting robust growth across its key segments despite the ongoing challenges of the COVID-19 pandemic. The company demonstrated resilience, with total revenues increasing by 6% to $257.1 billion and earnings from operations growing by 14% to $22.4 billion. This growth was largely driven by the UnitedHealthcare segment, which saw a 4% revenue increase, particularly benefiting from expansion in Medicare Advantage and Medicaid programs. The Optum segment was a significant contributor, with revenues surging by 21% to $136.3 billion, fueled by strong performance in OptumHealth and OptumRx. The company maintained a healthy return on equity of 24.9% and generated substantial cash flows from operations ($22.2 billion), underscoring its financial strength. UnitedHealth Group continued to return capital to shareholders through increased dividends and share repurchases. While the pandemic did introduce some operational impacts, such as temporary deferral of care affecting certain service volumes, the company effectively managed these challenges through strategic customer assistance programs and cost management initiatives. Looking ahead, UNH is poised for continued growth, further supported by strategic acquisitions, including the significant pending acquisition of Change Healthcare.
Financial Highlights
56 data points| Revenue | $257.14B |
| Cost of Revenue | $30.75B |
| Gross Profit | $226.40B |
| SG&A Expenses | $41.70B |
| Operating Expenses | $234.74B |
| Operating Income | $22.41B |
| Interest Expense | $1.66B |
| Net Income | $15.40B |
| EPS (Basic) | $16.23 |
| EPS (Diluted) | $16.03 |
| Shares Outstanding (Basic) | 949.00M |
| Shares Outstanding (Diluted) | 961.00M |
Key Highlights
- 1Total revenues increased by 6% to $257.1 billion in 2020, driven by growth across both UnitedHealthcare and Optum segments.
- 2Earnings from operations grew by 14% to $22.4 billion, showcasing strong operational performance.
- 3UnitedHealthcare segment revenues increased by 4% to $200.9 billion, aided by Medicare Advantage and Medicaid enrollment growth.
- 4Optum segment revenues saw a significant 21% increase to $136.3 billion, propelled by OptumHealth and OptumRx.
- 5Return on equity remained strong at 24.9%, demonstrating effective use of shareholder capital.
- 6Cash flow from operations was robust at $22.2 billion, indicating strong cash generation capabilities.
- 7The company increased its quarterly cash dividend by 15.5% to an annual rate of $5.00 per share, signaling confidence in future performance and commitment to shareholder returns.